BRPI0811016A2 - Proteína li truncada do papiloma vírus humano tipo 16 - Google Patents

Proteína li truncada do papiloma vírus humano tipo 16

Info

Publication number
BRPI0811016A2
BRPI0811016A2 BRPI0811016A BRPI0811016A2 BR PI0811016 A2 BRPI0811016 A2 BR PI0811016A2 BR PI0811016 A BRPI0811016 A BR PI0811016A BR PI0811016 A2 BRPI0811016 A2 BR PI0811016A2
Authority
BR
Brazil
Prior art keywords
human virus
protein
type
human
virus
Prior art date
Application number
Other languages
English (en)
Inventor
Yung Gu
Shaowei Li
Minxi Wei
Yangling Xian
Wenxin Luo
Ningshao Xia
Original Assignee
Beijing Wantai Biological Pharmacy Entpr Co Ltd
Univ Xiamen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Wantai Biological Pharmacy Entpr Co Ltd, Univ Xiamen filed Critical Beijing Wantai Biological Pharmacy Entpr Co Ltd
Publication of BRPI0811016A2 publication Critical patent/BRPI0811016A2/pt
Publication of BRPI0811016B1 publication Critical patent/BRPI0811016B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
BRPI0811016-6A 2007-04-29 2008-04-29 Proteína li truncada do papiloma vírus humano tipo 16 BRPI0811016B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN200710097762 2007-04-29
CN200710097762.8 2007-04-29
CN200810008761.6 2008-01-23
CN200810008761 2008-01-23
PCT/CN2008/000872 WO2008134934A1 (en) 2007-04-29 2008-04-29 A truncated l1 protein of human papillomavirus 16

Publications (2)

Publication Number Publication Date
BRPI0811016A2 true BRPI0811016A2 (pt) 2015-01-27
BRPI0811016B1 BRPI0811016B1 (pt) 2021-09-21

Family

ID=39943110

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811016-6A BRPI0811016B1 (pt) 2007-04-29 2008-04-29 Proteína li truncada do papiloma vírus humano tipo 16

Country Status (7)

Country Link
US (1) US9428555B2 (pt)
EP (1) EP2154147B1 (pt)
CN (1) CN101293918B (pt)
BR (1) BRPI0811016B1 (pt)
DK (1) DK2154147T3 (pt)
HK (1) HK1124868A1 (pt)
WO (1) WO2008134934A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101570571B (zh) 2007-04-29 2012-07-11 北京万泰生物药业股份有限公司 截短的人乳头瘤病毒18型l1蛋白
BRPI0811016B1 (pt) 2007-04-29 2021-09-21 Xiamen Innovax Biotech Co., Ltd. Proteína li truncada do papiloma vírus humano tipo 16
DK2154149T3 (da) * 2007-05-29 2019-10-14 Univ Xiamen En trunkeret l1-protein af human papillomavirus 6
DK2589604T3 (en) 2010-07-02 2017-01-16 Univ Xiamen TRUNCATED L1 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE 52
CN102229660B (zh) 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
CN102747047B (zh) * 2012-02-28 2016-03-23 厦门大学 人乳头瘤病毒型别杂合病毒样颗粒及其制备方法
CN105039358B (zh) * 2013-12-03 2020-02-28 北京康乐卫士生物技术股份有限公司 58型重组人乳头瘤病毒病毒样颗粒及其制备方法
US10413603B2 (en) * 2014-06-19 2019-09-17 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for improved human papilloma virus constructs
RU2677336C2 (ru) * 2014-12-26 2019-01-16 Айджин, Инк. Способ получения вирусоподобных частиц папилломавируса человека
CN107188932B (zh) * 2016-03-15 2020-02-11 中国医学科学院基础医学研究所 截短型人乳头瘤病毒16型l1蛋白及其应用
CN107188966B (zh) 2016-03-15 2020-03-31 中国医学科学院基础医学研究所 一种乳头瘤病毒嵌合蛋白及其用途
CN106884017B (zh) * 2016-12-28 2024-03-26 中国食品药品检定研究院 用于包装柯萨奇病毒b5假病毒的重组表达质粒、假病毒、试剂盒和方法
CN109251235B (zh) * 2017-07-14 2021-04-27 厦门大学 一种人乳头瘤病毒16型l1蛋白的突变体
KR20210018351A (ko) * 2018-06-04 2021-02-17 시아먼 유니버시티 타입 39 인유두종 바이러스 l1 단백질의 돌연변이체
WO2021013069A1 (zh) * 2019-07-19 2021-01-28 神州细胞工程有限公司 嵌合的人乳头瘤病毒11型l1蛋白
CN114716561B (zh) 2021-01-04 2024-03-12 中国医学科学院基础医学研究所 一种人乳头瘤病毒31型嵌合蛋白及其用途
CN114716560B (zh) 2021-01-04 2024-02-02 中国医学科学院基础医学研究所 一种人乳头瘤病毒18型嵌合蛋白及其用途
CN114292321B (zh) * 2021-12-30 2023-06-16 重庆澳龙生物制品有限公司 可溶性表达eg95蛋白及其制备方法和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2157932C (en) 1993-03-09 2011-10-11 Robert C. Rose Production of human papillomavirus capsid protein and virus-like particles
AUPM566794A0 (en) 1994-05-17 1994-06-09 University Of Queensland, The Process and product
IL113817A (en) 1994-06-30 2001-03-19 Merck & Co Inc Polynucleotide for vaccination against the umbilical cord virus
ES2264563T3 (es) 1994-10-07 2007-01-01 Loyola University Of Chicago Particulas semejantes al virus del papiloma, proteinas de fusion y procedimiento para su preparacion.
IL117459A (en) 1995-03-22 2005-11-20 Merck & Co Inc Dna encoding human papillomavirus type 18
US5840306A (en) * 1995-03-22 1998-11-24 Merck & Co., Inc. DNA encoding human papillomavirus type 18
US5820870A (en) 1995-03-22 1998-10-13 Merck & Co., Inc. Recombinant human papillomavirus type 18 vaccine
US6908615B1 (en) * 1996-03-18 2005-06-21 Merck & Co., Inc. DNA encoding human papilloma virus type 18
US7351533B2 (en) 1997-09-05 2008-04-01 Medimmune, Inc. In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents
US6228368B1 (en) 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
US20020039584A1 (en) * 1998-02-20 2002-04-04 Medigene Ag Papilloma virus capsomere vaccine formulations and methods of use
US7182947B2 (en) 1998-02-20 2007-02-27 Medigene Ag Papillomavirus truncated L1 protein and fusion protein constructs
US20020193565A1 (en) * 1998-03-27 2002-12-19 Stanley Margaret Anne Antigen preparation and use
BR9913026A (pt) 1998-08-14 2001-09-25 Merck & Co Inc Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano
US6551597B1 (en) * 1999-03-18 2003-04-22 President & Fellows Of Harvard College Vaccine compositions for human papillomavirus
DE10059630A1 (de) 2000-12-01 2002-06-06 Medigene Ag Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor
WO2003018624A1 (en) 2001-08-31 2003-03-06 University Of Cape Town Vectors, constructs, and transgenic plants for hpv-11 and hpv-16 l1 capsid protein
GB0206360D0 (en) 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
WO2003093437A2 (en) 2002-05-02 2003-11-13 University Of Rochester Production of papillomavirus vaccines in plants
CN1293093C (zh) 2002-08-30 2007-01-03 马润林 乳头瘤病毒衣壳蛋白的原核制备和应用
KR20050086924A (ko) * 2002-12-20 2005-08-30 글락소스미스클라인 바이오로지칼즈 에스.에이. Ｈｐｖ-16 ｌ1 ｖｌｐ 및 ｈｐｖ-18 ｌ1 ｖｌｐ 백신
MY139500A (en) 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
CN1683010A (zh) 2005-02-06 2005-10-19 哈尔滨医科大学 人乳头瘤病毒型双价病毒样颗粒混合蛋白抗原及构建方法
CN100392084C (zh) * 2006-03-13 2008-06-04 曾毅 含密码子优化型hpv16l1基因的重组腺病毒
CN101153280B (zh) * 2006-09-29 2015-08-19 厦门大学 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法
JP2010520874A (ja) 2007-03-09 2010-06-17 メルク・シャープ・エンド・ドーム・コーポレイション パピローマウイルスワクチン組成物
BRPI0811016B1 (pt) 2007-04-29 2021-09-21 Xiamen Innovax Biotech Co., Ltd. Proteína li truncada do papiloma vírus humano tipo 16
CN101570571B (zh) 2007-04-29 2012-07-11 北京万泰生物药业股份有限公司 截短的人乳头瘤病毒18型l1蛋白
EP2907821B1 (en) 2007-05-29 2016-12-28 Xiamen University Method for producing a N-terminaly truncated L1 protein of human papillomavirus (HPV)

Also Published As

Publication number Publication date
EP2154147A4 (en) 2011-11-02
EP2154147B1 (en) 2015-10-07
DK2154147T3 (en) 2015-12-07
HK1124868A1 (en) 2009-07-24
US9428555B2 (en) 2016-08-30
US20100255031A1 (en) 2010-10-07
WO2008134934A1 (en) 2008-11-13
CN101293918A (zh) 2008-10-29
EP2154147A1 (en) 2010-02-17
CN101293918B (zh) 2013-03-27
BRPI0811016B1 (pt) 2021-09-21

Similar Documents

Publication Publication Date Title
BRPI0811016A2 (pt) Proteína li truncada do papiloma vírus humano tipo 16
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
BRPI0813647A2 (pt) Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
DK1959991T3 (da) Terapeutisk vaccine
DK3118220T3 (da) Protein
BRPI0911743A2 (pt) "peptídeo"
DE602008006310D1 (de) Endoskopischer Reprozessor
BRPI1011813A2 (pt) "inalador"
BRPI1013015A2 (pt) "osteosíntese com nanoprata"
ATE544443T1 (de) Haarpflegezusammensetzung
ITCO20080005A1 (it) "shaker monouso"
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
BRPI0811819A2 (pt) "válvulas de segurança do tipo gaveta"
BRPI0814971A2 (pt) Proteína
DK2144905T3 (da) Terapeutiske midler
BRPI0817822A2 (pt) Preparação sólida farmacêutica do tipo matriz
BRPI0814188A2 (pt) Formulações
BRPI1011581A2 (pt) Preparação de proteína de soja isolada usando extração de cloreto de cálcio ("s703")
BRPI0921947A2 (pt) formulações de proteína terapêutica
BRPI0717212A2 (pt) fralda descartÁvel tipo calÇa
HK1124344A1 (zh) 截短的人乳頭瘤病毒 蛋白
BRPI1007603A2 (pt) "composição de tratamento do cabelo"
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
BRPI0815818A2 (pt) proteína l1 truncada do papiloma vírus humano tipo 18

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: XIAMEN UNIVERSITY (CN) ; XIAMEN INNOVAX BIOTECH CO., LTD. (CN)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/04/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.